HomeExploredocfliq AILearningEvents
GroupsCasesPublications
Article · 4 min read

Formulary Management: Promoting Safe, Effective and Cost-Conscious Medication Use

Formulary management is not simply about deciding which medicines to stock; it is about ensuring that medicines are selected, used, and monitored appropriately to support better patient care.

A
Aminya

Physician · Critical Care · 27 Oct 2026

Introduction

Formulary management is an essential component of medication management in hospitals and healthcare systems. It involves the systematic selection, evaluation, approval, and ongoing review of medicines to ensure that patients have access to treatments that are clinically appropriate, safe, effective, and cost-effective.

A hospital formulary is more than a list of approved medicines. It is part of a broader system that guides prescribing, dispensing, administration, monitoring, and the appropriate use of medicines. A well-managed formulary can help standardise clinical practice, reduce unnecessary variation, support medication safety, and promote the responsible use of healthcare resources.

What Is a Hospital Formulary?

A hospital formulary is a regularly updated list of medicines approved for use within a healthcare institution, supported by relevant prescribing information, clinical guidelines, restrictions, and medication-use policies.

Formulary decisions are generally overseen by a Pharmacy and Therapeutics (P&T) Committee, comprising pharmacists, physicians, other healthcare professionals, and relevant institutional representatives. The committee evaluates medicines using clinical evidence and considers the needs of the patient population served by the institution.

Key Principles of Formulary Management

1. Evidence-based medicine selection

Medicines should be assessed using reliable clinical evidence, including relevant clinical trials, systematic reviews, clinical guidelines, and safety information. The evaluation should consider the medicine’s effectiveness in the intended patient population and its benefits compared with existing treatment options.

2. Safety and risk assessment

Safety is a central consideration in formulary decisions. Assessment should include known adverse effects, contraindications, clinically significant drug interactions, medication-error risks, and requirements for laboratory or clinical monitoring. High-alert medicines and medicines requiring specialised handling may need additional safeguards.

3. Comparative effectiveness and therapeutic alternatives

New medicines should be evaluated against available treatments, including established therapies and suitable generic alternatives. The aim is to identify treatments that provide meaningful clinical benefits and meet the needs of patients while avoiding unnecessary duplication within the formulary.

4. Cost-effectiveness and affordability

Medicine selection should consider acquisition costs, monitoring requirements, administration costs, and other relevant healthcare resource implications. However, the lowest-priced option is not necessarily the best choice. Economic considerations should be assessed alongside clinical outcomes, safety, and patient needs.

5. Availability and practical implementation

The committee should consider medicine availability, storage requirements, supply reliability, staff training, administration procedures, and compatibility with existing pharmacy and clinical information systems. These factors influence whether a medicine can be used safely and consistently in routine practice.

How Does the Formulary Management Process Work?

A structured formulary process typically includes the following steps:

  • Request and prioritisation: A clinician or department submits a request for a new medicine or a change to an existing formulary entry.

  • Clinical and economic evaluation: The pharmacy team prepares a medicine review summarising the evidence on efficacy, safety, comparative effectiveness, costs, and implementation requirements.

  • Multidisciplinary review: The P&T Committee evaluates the evidence and determines whether the medicine should be included, restricted, or declined.

  • Approval and implementation: Approved decisions are incorporated into the formulary, prescribing systems, relevant policies, and clinical guidance. Healthcare professionals are informed of any changes.

  • Monitoring and reassessment: Medicine utilisation, safety signals, clinical outcomes, expenditure, and adherence to restrictions are reviewed to determine whether further action is needed.

The Role of Healthcare Professionals

Pharmacists play a key role in preparing medicine evaluations, identifying medication-related risks, monitoring utilisation, and supporting appropriate prescribing. Physicians contribute clinical expertise and assess the relevance of available treatments to patient care. Nurses and other healthcare professionals provide valuable insights into medicine administration, monitoring, and practical implementation.

Collaboration among these groups helps ensure that formulary decisions reflect both the available evidence and the realities of clinical practice.

Why Is Ongoing Review Important?

Formulary management is a continuous process. New clinical evidence, updated treatment guidelines, emerging safety concerns, medicine shortages, changing costs, and evolving patient needs may require existing decisions to be reviewed.

Medication-use evaluation can help identify inappropriate prescribing, unnecessary duplication, opportunities for safer alternatives, and areas where clinical guidance or staff education may be needed. Periodic reassessment also helps determine whether recently introduced medicines are being used appropriately and delivering the expected benefits.

Conclusion

Effective formulary management balances clinical evidence, patient safety, therapeutic value, and responsible resource utilisation. A transparent, multidisciplinary, and regularly reviewed formulary system can support consistent prescribing practices and improve the quality of medication use across healthcare settings.

References

  1. Ciccarello C, Billstein Leber M, Leonard MC, et al. ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. American Journal of Health-System Pharmacy. 2021;78(10):907–918. Read the guideline. Oxford Academic +1
  2. American Society of Health-System Pharmacists (ASHP). Medication Formulary System Management. ASHP Policy Position. Access the policy

The author's professional view. Not a peer-reviewed publication.

News

All news
  • Help·
  • Guides·
  • Privacy·
  • Terms·
  • Cookies
  • © 2026 docfliq

We use cookies to ensure the proper functioning of the platform and to improve your experience. This includes strictly necessary cookies and optional analytics cookies. If you reject optional cookies, only cookies necessary to provide you the services will be used. You may change your preferences at any time by clicking ‘’.

·
Back

Replies

Loading…

Sign in to reply